Iron isomaltoside is superior to iron sucrose in increasing hemoglobin in gynecological patients with iron deficiency anemia.

Authors

Richard Derman, Thomas Jefferson UniversityFollow
Eloy Roman, Lakes Research
Gioi N. Smith-Nguyen, Grossmont Center for Clinical Research
Maureen M. Achebe, Brigham and Women’s Hospital, Dana Farber Cancer Institute
Lars L. Thomsen, Pharmacosmos A/S,
Michael Auerbach, Georgetown University School of Medicine

Document Type

Article

Publication Date

5-18-2018

Comments

This article has been peer reviewed. It is the author’s final published version in American Journal of Hematology, 
Volume 93, Issue 6, May 2018, Pages E148-E150.

The published version is available at https://doi.org/10.1002/ajh.25094. Copyright © Derman et al.

Recommended Citation

Derman, Richard; Roman, Eloy; Smith-Nguyen, Gioi N.; Achebe, Maureen M.; Thomsen, Lars L.; and Auerbach, Michael, "Iron isomaltoside is superior to iron sucrose in increasing hemoglobin in gynecological patients with iron deficiency anemia." (2018). Global Health Articles. Article 10.
https://jdc.jefferson.edu/gha/10

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License

Language

English